Hostname: page-component-848d4c4894-hfldf Total loading time: 0 Render date: 2024-05-13T19:17:27.462Z Has data issue: false hasContentIssue false
  • English
  • Français

Carbamazepine and Forme Fruste Neuroleptic Malignant Syndrome

Published online by Cambridge University Press:  02 January 2018

Tim Dalkin  and
Alan S. Lee
Tim Dalkin*
Affiliation:
Department of Psychiatry, B Floor, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH
Alan S. Lee
Affiliation:
University Hospital, Nottingham
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Extract

A woman developed rigidity, autonomic instability and altered consciousness after taking an overdose of trifluoperazine and carbamazepine. A diagnosis of NMS was made despite the absence of fever, as carbamazepine might modify the presentation of NMS.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 157 , Issue 3 , September 1990 , pp. 437 - 438
Copyright
Copyright © Royal College of Psychiatrists, 1990 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adityanjee, , Singh, S., Singh, G., et al (1988) Spectrum concept of neuroleptic malignant syndrome. British Journal of Psychiatry, 153, 107–111.Google Scholar
Birkhimer, L. J., Curtis, J. L. & Jann, M. W. (1985) Use of carbamazepine in psychiatric disorders. Clinical Pharmacy, 4, 423–434.Google Scholar
Bursztyn, M., Nussinovich, N. & Rosenthal, T. (1987) Muscle enzyme elevation in carbamazepine intoxication. Israeli Journal of Medical Science, 23, 905.Google Scholar
Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 79–83.Google Scholar
Evans, R. W. & Gualtieri, C. T. (1985) Carbamazepine: a neuropsychological and psychiatric profile. Clinical Neuropharmacology, 8, 221–241.Google Scholar
Goldwasser, H. D., Hooper, J. F. & Spears, N. M. (1989) Concomitant treatment of neuroleptic malignant syndrome and psychosis. British Journal of Psychiatry, 154, 102–104.Google Scholar
Keck, P. E., Pope, H. G. & McElroy, S. L. (1987) Frequency and presentation of neuroleptic malignant syndrome: a prospective study. American Journal of Psychiatry, 144, 1344–1346.Google Scholar
Levenson, J. L. (1985) Neuroleptic malignant syndrome. American Journal of Psychiatry, 142, 1137–1145.Google Scholar
Müller, T., Becker, T. & Fritze, J. (1988) Neuroleptic malignant syndrome after clozapine plus carbamazepine. Lancet, ii, 1500.Google Scholar
Sullivan, C. F. (1987) A possible variant of the neuroleptic malignant syndrome. British Journal of Psychiatry, 151, 689–690.Google Scholar
Szabadi, E. (1984) Neuroleptic malignant syndrome. British Medical Journal, 288, 1399–1400.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.